University of Vermont

The University of Vermont Cancer Center


Sarcomas Clinical Trials

The University of Vermont Cancer Center has many trials focused on sarcoma research.

Status: Active - Recruiting
Study Title: A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas who Either Relapsed or were Refractory to Prior Non-Adjuvant Chemotherapy

Purpose: The purpose of this study is to determine the efficacy and safety of aldoxorubicin in subjects with metastatic, locally advanced, or unresectable soft tissue sarcomas. Identifier: NCT02049905
Contact: Kate Murray (802) 656-9401
Institution Number: 14-408
Protocol Research Type: Industry Sponsored
Status: Active - Closed to Accrual
Study Title: A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Purpose: Researchers want to find out if an Investigational drug called TH-302 can help patients with advanced soft tissue sarcoma when it is combined with doxorubicin.  The purpose of this study is to gather information on the safety and effect on your cancer of TH-302 in combination with doxorubicin.  The study will also look at how the drug is processed in the body. Identifier: NCT01440088
Primary/Site/Co Investigator:
Contact: Karen Lepuschenko (802) 656-9924
Institution Number: M12-225
Protocol Research Type: Industry Sponsored

Last modified June 04 2015 10:16 AM